Kala Pharmaceuticals Statistics

Total Valuation

KALA has a market cap or net worth of $18.03 million. The enterprise value is $3.45 million.

Market Cap	18.03M
Enterprise Value	3.45M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

KALA has 2.82 million shares outstanding. The number of shares has increased by 59.94% in one year.

Shares Outstanding	2.82M
Shares Change (YoY)	+59.94%
Shares Change (QoQ)	+6.48%
Owned by Insiders (%)	17.95%
Owned by Institutions (%)	22.73%
Float	2.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.40
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.34, with a Debt / Equity ratio of 4.84.

Current Ratio	6.34
Quick Ratio	n/a
Debt / Equity	4.84
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.26

Financial Efficiency

Return on equity (ROE) is -282.80% and return on invested capital (ROIC) is -88.81%.

Return on Equity (ROE)	-282.80%
Return on Assets (ROA)	-66.00%
Return on Capital (ROIC)	-88.81%
Revenue Per Employee	n/a
Profits Per Employee	-$981,372
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.37% in the last 52 weeks. The beta is -1.84, so KALA's price volatility has been lower than the market average.

Beta (1Y)	-1.84
52-Week Price Change	-59.37%
50-Day Moving Average	7.39
200-Day Moving Average	8.90
Relative Strength Index (RSI)	28.08
Average Volume (30 Days)	20,450

Short Selling Information

The latest short interest is 5,978, so 0.21% of the outstanding shares have been sold short.

Short Interest	5,978
Short Previous Month	12,074
Short % of Shares Out	0.21%
Short % of Float	0.26%
Short Ratio (days to cover)	0.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.92M
Pretax Income	-42.20M
Net Income	-42.20M
EBITDA	-35.91M
EBIT	-36.39M
Earnings Per Share (EPS)	-$17.35

Full Income Statement

Balance Sheet

The company has $50.90 million in cash and $36.32 million in debt, giving a net cash position of $14.57 million or $5.17 per share.

Cash & Cash Equivalents	50.90M
Total Debt	36.32M
Net Cash	14.57M
Net Cash Per Share	$5.17
Equity / Book Value	7.50M
Book Value Per Share	2.66
Working Capital	44.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.93 million and capital expenditures -$563,000, giving a free cash flow of -$28.49 million.

Operating Cash Flow	-27.93M
Capital Expenditures	-563,000
Free Cash Flow	-28.49M
FCF Per Share	-$11.72

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.94%
Shareholder Yield	-59.94%
Earnings Yield	-234.11%
FCF Yield	-158.06%

Analyst Forecast

The average price target for KALA is $18.00, which is 181.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	181.25%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	3